IRVINE, Calif.--(BUSINESS WIRE)--Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations in urodynamics, today announced the initial closing of its $23M Series A financing round led by Laborie Medical Technologies, a leading global provider of urology diagnostic and therapeutic solutions.

IRVINE，Calif.-（BUSINESS WIRE）-Bright Uro是一家医疗器械公司，致力于通过尿动力学创新改变下尿路症状（LUTS）的护理，今天宣布首次关闭其2300万美元的a系列融资由Laborie medical Technologies领导，Laborie medical Technologies是全球领先的泌尿外科诊断和治疗解决方案提供商。

The Series A funding round includes investment from Laborie and other existing investors in the Company. Funding will be used to achieve FDA 510(k) clearance of the Glean™ Urodynamics System (Glean) and launch the product in the U.S. in 2024. Glean is a comprehensive system that enables wireless, catheter-free urodynamics and aims to revolutionize the testing process by giving clinicians more accurate data with actionable insight to aid in clinical decision-making..

A系列资金轮包括Laborie和公司其他现有投资者的投资。资金将用于实现FDA 510（k）Glean的清除™Urodynamics系统（Glean）并于2024年在美国推出该产品。Glean是一个全面的系统，可实现无线，无导管的尿动力学，旨在通过为临床医生提供更准确的数据和可操作的见解来帮助临床决策，从而彻底改变测试过程。。

“Laborie looks forward to leveraging our expertise and leadership in the global urology market to support the Bright Uro team,” said Michael Frazzette, President & CEO of Laborie. “The Glean system is a very novel technology. This investment furthers our commitment to preserve and restore human dignity while improving patient access and outcomes.”.

Laborie总裁兼首席执行官Michael Frazzette说：“Laborie期待利用我们在全球泌尿外科市场的专业知识和领导力来支持Bright Uro团队。”。“Glean系统是一项非常新颖的技术，这项投资进一步推动了我们在保持和恢复人的尊严，同时改善患者的获取和结果方面的承诺。”。

The Company also announced the appointment of two industry veterans to its executive team, Suranjan Roychowdhury, Ph.D. as Chief Product Development Officer and Casey Kanel as Chief Commercial Officer. Dr. Roychowdhury is a seasoned professional with extensive experience leading R&D and Clinical at both startups and large medical device companies, including AMS, Cogentix, and Boston Scientific.

该公司还宣布任命两名行业退伍军人到其执行团队Suranjan Roychowdhury博士担任首席产品开发官，Casey Kanel担任首席商业官。Roychowdhury博士是一位经验丰富的专业人士，在初创公司和大型医疗器械公司（包括AMS，Cogentix和Boston Scientific）拥有丰富的研发和临床经验。

Casey Kanel brings an impressive track record of commercial success with over 30 years of experience in urology and urogynecology device sales. After spending the majority of his career with Medtronic, Casey led the U.S. launch of Bulkamid for Contura until their successful acquisition by Axonics in 2020..

凯西·坎内尔（Casey Kanel）拥有30多年泌尿外科和泌尿妇科设备销售经验，在商业上取得了令人瞩目的成功记录。在与美敦力公司一起度过大部分职业生涯之后，凯西领导美国推出Bulkamid for Contura，直到2020年成功收购Axonics。。

Bright Uro Founder and CEO Derek Herrera stated, “I am so proud of our team for achieving this incredible milestone! In just 15 months since securing an exclusive IP license from the Cleveland Clinic, we have built, tested, and manufactured not one device, but a highly complex system, including single-use disposable sensors, male and female insertion tools, a reusable uroflowmeter, and multiple software apps.

Bright Uro创始人兼首席执行官Derek Herrera表示，“我为我们的团队实现这一令人难以置信的里程碑感到非常自豪！在获得克利夫兰诊所独家IP许可后的短短15个月内，我们构建，测试和制造了不是一台设备，而是一个高度复杂的系统，包括单次使用一次性传感器，男性和女性插入工具，可重复使用的尿流计和多种软件应用程序。

At Bright Uro, our people are our most important asset. Casey and Suranjan are the right leaders joining at the perfect time to have an exponential impact as we continue on the path to bring Glean to market.”.

在Bright Uro，我们的人是我们最重要的资产。Casey和Suranjan是当时加入的合适领导者，在我们继续走向将Glean推向市场的道路上产生指数级影响。

About Bright Uro

关于明亮的Uro

Based in Irvine, Calif., Bright Uro’s mission is to transform care of lower urinary tract symptoms (LUTS) with its innovative technology that is poised to disrupt outdated urodynamics approaches. The Company’s investigational Glean™ Urodynamics System is designed to enable wireless, catheter-free urodynamics monitoring, with the ultimate goal of improving patient comfort and clinical outcomes.

总部设在加利福尼亚州欧文市的Bright Uro的使命是通过其创新技术改变下尿路症状（LUTS）的护理，该技术有望破坏过时的尿动力学方法。公司的调查收集™尿动力学系统旨在实现无线，无导管尿动力学监测，最终目标是改善患者舒适度和临床结果。

For more information, visit www.brighturo.com..

欲了解更多信息，请访问www.brighturo.com。。

About Laborie Medical Technologies

关于劳动医疗技术

Headquartered in Portsmouth, New Hampshire, Laborie is a global medical technology company focused on Urology, Urogynecology, Gastroenterology, Obstetrics, Gynecology & Neonatal Health. We manufacture and deliver high-quality, high-impact diagnostic and therapeutic products that help clinicians and hospitals preserve and restore patient dignity.

Laborie总部设在新罕布什尔州朴茨茅斯，是一家专注于泌尿外科，泌尿妇科，消化内科，产科，妇科和新生儿健康的全球医疗技术公司。我们制造和提供高质量，高影响力的诊断和治疗产品，帮助临床医生和医院维护和恢复患者的尊严。

Clinicians and hospitals look to us as the market-leading experts in our business segments, and we support our products with a world-class clinical education & information program. Laborie is a portfolio company of Patricia Industries. For more information, visit www.laborie.com..

临床医生和医院将我们视为我们业务领域的市场领先专家，我们通过一流的临床教育和信息计划支持我们的产品。Laborie是Patricia Industries的投资组合公司。欲了解更多信息，请访问www.laborie.com。。